Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 4
145
Views
3
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Pharmacokinetics of felbinac after intravenous administration of felbinac trometamol in rats

, , , , , , , & show all
Pages 340-348 | Received 15 Oct 2010, Accepted 29 Nov 2010, Published online: 23 Dec 2010

References

  • Ayrton A, Morgan P. (2001). Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469–497.
  • Cui Y, Lin X, Guan TT, Zhang Y, Tang X. (2010). A new rapid ultra-performance liquid chromatography method for the pharmacokinetic and bioavailability study of diclofenac sodium aqueous injection and lipid microsphere injection in rats. Biomed Chromatogr 24:406–412.
  • Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–1095.
  • Food and Drug Administration. (2001). Guidance for Industry, Bioanalytical Method Validation. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf
  • Gu J, Zhong D, Chen X. (1999). Analysis of O-glucuronide conjugates in urine by electrospray ion trap mass spectrometry. Fresenius J Anal Chem 365:553–558.
  • Gupta A, Hammarlund-Udenaes M, Chatelain P, Massingham R, Jonsson EN. (2006). Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding. Biopharm Drug Dispos 27:291–297.
  • Hayashi T, Amino M, Tomita M, Takagi T, Hirai T, Inokawa Y, Yamashita N. (1987). Absorption, distribution, metabolism and excretion of LM-001 in rats, rabbits and dogs after intravenous administration. Jpn Pharmacol Ther 15:135–155.
  • Hla T, Neilson K. (1992). Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384–7388.
  • Kunin CM, Dornbush AC, Finland M. (1959). Distribution and excretion of four tetracycline analogues in normal young men. J Clin Invest 38:1950–1963.
  • Levsen K, Schiebel HM, Behnke B, Dötzer R, Dreher W, Elend M, Thiele H. (2005). Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. J Chromatogr A 1067:55–72.
  • Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y. (2003). Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425–461.
  • Musick TJ, Gohdes M, Duffy A, Erickson DA, Krieter PA. (2008). Pharmacokinetics, disposition, and metabolism of bicifadine in the mouse, rat, and monkey. Drug Metab Dispos 36:241–251.
  • Nakano E, Yoshioka T, Matsuda M, Sonoda T, Yano H, Ihara Y, Kuroda H, Kishimoto T, Sakurai T, Uchida K. (1990). [Clinical effect of LM-001, prostaglandin synthetic inhibitor, on pain from urinary tract stone and vesical urgency after operation of the bladder or prostate]. Hinyokika Kiyo 36:635–642.
  • Niemeijer NR, Gerding TK, De Zeeuw RA. (1991). Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol. Drug Metab Dispos 19:20–23.
  • Ong KS, Tan JM. (2004). Preoperative intravenous tramadol versus ketorolac for preventing postoperative pain after third molar surgery. Int J Oral Maxillofac Surg 33:274–278.
  • Paci A, Rezai K, Deroussent A, De Valeriola D, Re M, Weill S, Cvitkovic E, Kahatt C, Shah A, Waters S, Weems G, Vassal G, Lokiec F. (2006). Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors. Drug Metab Dispos 34:1918–1926.
  • Seymour RA, Moore U, Hawkesford J, Coulthard P, Jackson-Leech D, Thomas D, Hill M, Combs ML, Renton T, McGurk M. (2000). An investigation into the efficacy of intravenous diclofenac in post-operative dental pain. Eur J Clin Pharmacol 56:447–452.
  • Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. (2000). Bioanalytical method validation–a revisit with a decade of progress. Pharm Res 17:1551–1557.
  • Shiba T, Shikata Y, Takagawa N, Sasaki M, Yanaka M, Sugiyama Y, Murai E, Nishiki K, Inomata N, Hama T, Kawada M, Hisaichi S, Hasui A, Hattori K, Shirakawa K, Konishi R. (1992). Antiinflammatory and analgesic activities of felbinac adhesive preparation (felbinac patch). Jpn Pharmacol Ther 20:81–94.
  • Shinkai N, Korenaga K, Takizawa H, Mizu H, Yamauchi H. (2008). Percutaneous penetration of felbinac after application of transdermal patches: relationship with pharmacological effects in rats. J Pharm Pharmacol 60:71–76.
  • Tanswell P, Koup J. (1993). TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis program. Int J Clin Pharmacol Ther Toxicol 31:514–520.
  • Verbeeck RK, Blackburn JL, Loewen GR. (1983). Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 8:297–331.
  • Vermeir M, Naessens I, Remmerie B, Mannens G, Hendrickx J, Sterkens P, Talluri K, Boom S, Eerdekens M, van Osselaer N, Cleton A. (2008). Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans. Drug Metab Dispos 36:769–779.
  • Wang W, Ou HY, Xiao BQ, Huang YK, Yang W, Wang XS. (2009). The study of abirritation of a first type of new drug, felbinac trometamol injection. Chin J Med Guide 11:1327–1329.
  • Wu H, Chen Z, Sun G, Gu K, Pan Y, Hao J, Du Y, Ning J. (2009). Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain. J Exp Clin Cancer Res 28:33.
  • Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692–2696.
  • Zhang C, Wang L, Yang W, Wang X, Fawcett JP, Sun Y, Gu J. (2009). Validated LC-MS/MS assay for the determination of felbinac: Application to a preclinical pharmacokinetics study of felbinac trometamol injection in rat. J Pharm Biomed Anal 50:41–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.